Schedule 13G ownership disclosure

Tarsus Pharmaceuticals Inc

Security class unavailable · CUSIP: 87650L103

Event date: 2023-04-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,398,983
Percent of class
5.2200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-23-002078
Form type
SC 13G
Filer
Cowen Financial Products LLC
CIK
CIK 1771015
Filed
May 05, 2023
Reporting period
Apr 28, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub